Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 49, 2020 - Issue 1-2
266
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Association of HLA-G 3’UTR Polymorphisms with Soluble HLA-G Levels and Disease Activity in Patients with Rheumatoid Arthritis: A Case-Control Study

, , , &

References

  • Agnihotri V, Gupta A, Kumar R, et al. (2017). Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population. Hum Immunol, 78(2), 172–178. doi:10.1016/j.humimm.2016.12.007.
  • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. (2002). Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum, 46, 328–346. doi:10.1002/art.10148.
  • Baricordi OR, Govoni M, Rizzo R, Trotta F. (2007). In rheumatoid arthritis, a polymorphism in the HLA‐G gene concurs in the clinical response to methotrexate treatment. Ann Rheum Dis, 66, 1125–1126. doi:10.1136/ard.2006.064022.
  • Bortolotti D, Gentili V, Rotola A, et al. (2014). Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions. World J Methodol, 4, 11–25. doi:10.5662/wjm.v4.i1.11.
  • Carlini F, Ferreira V, Buhler S, et al. (2016). Association of HLA-A and non-classical HLA class I alleles. PLoS One, 11, e0163570. doi:10.1371/journal.pone.0163570.
  • Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, et al. (2011). A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol, 28, 3069–3086. doi:10.1093/molbev/msr138.
  • Castelli EC, Moreau P, Oya E Chiromatzo A, et al. (2009). In silico analysis of microRNAS targeting the HLA-G 3ʹ untranslated region alleles and haplotypes. Hum Immunol, 70, 1020–1025. doi:10.1016/j.humimm.2009.07.028.
  • Castelli EC, Ramalho J, Porto IOP, et al. (2014). Insights into HLA-G genetics provided by worldwide haplotype diversity. Front Immunol, 5, 476. doi:10.3389/fimmu.2014.00476.
  • Catamo E, Addobbati C, Segat L, et al. (2014). HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients. Tissue Antigens, 84, 308–315. doi:10.1111/tan.12396.
  • Chinniah R, Rajendran MS, Sivanadham R, et al. (2019). Association of HLA class II alleles/haplotypes and amino acid variations in the peptide binding pockets with rheumatoid arthritis. Int J Rheum Dis. doi:10.1111/1756-185X.13612
  • Degani Veit T, Bogo Chies JA, Switala M, et al. (2015). The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS ONE 10, 10. doi:10.1371/journal.pone.0123838.
  • Donadi EA, Castelli EC, Arnaiz-Villena A, et al. (2011). Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci CMLS, 68, 369–395. doi:10.1007/s00018-010-0580-7.
  • Durmanova V, Bandzuchova H, Zilinska Z, et al. (2019). Association of HLA-G polymorphisms in the 3ʹUTR region and soluble HLA-G with kidney graft outcome. Immunol Invest, 48, 644–658. doi:10.1080/08820139.2019.1610888.
  • Funovits J, Aletaha D, Bykerk V, et al. (2010). The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological report phase I. Ann Rheum Dis, 69, 1589–1595. doi:10.1136/ard.2010.130310.
  • Gautam S, Tolahunase M, Kumar U, Dada R. (2019). Impact of yoga based mind-body intervention on systemic inflammatory markers and co-morbid depression in active rheumatoid arthritis patients: A randomized controlled trial. Restor Neurol Neurosci, 37, 41–59. doi:10.3233/RNN-180875.
  • Gregori S, Amodio G, Quattrone F, Panina-Bordignon P. (2015). HLA-G orchestrates the early interaction of human trophoblasts with the maternal niche. Front Immunol, 6, 128. doi:10.3389/fimmu.2015.00128.
  • Hashemi M, Mokhtari M, Khazaeian S, et al. (2017). Evaluation of HLA-G 14-bp ins/del and +3142G>C polymorphisms with susceptibility to recurrent spontaneous abortion. Taiwan J Obstet Gynecol, 56, 276–280. doi:10.1016/j.tjog.2017.04.002.
  • Hashemi M, Sandoughi M, Fazeli SA, et al. (2016). Evaluation of HLA-G 14 bp Ins/Del and +3142G>C polymorphism with susceptibility and early disease activity in rheumatoid arthritis. Adv Med, 2016, 4985745. doi:10.1155/2016/4985745.
  • Hoy DG, Smith E, Cross M, et al. (2015). Reflecting on the global burden of musculoskeletal conditions: Lessons learnt from the global burden of disease 2010 study and the next steps forward. Ann Rheum Dis, 74, 4–7. doi:10.1136/annrheumdis-2014-205393.
  • Hviid TVF, Christiansen OB. (2005). Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G–possible implications for human reproduction and autoimmune disease. Hum Immunol, 66, 688–699. doi:10.1016/j.humimm.2005.03.003.
  • Hviid TVF, Hylenius S, Rørbye C, Nielsen LG. (2003). HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics, 55, 63–79. doi:10.1007/s00251-003-0547-z.
  • Indian Genome Variation Consortium. (2008). Genetic landscape of the people of India: A canvas for disease gene exploration. J Genet, 87, 3–20. doi:10.1007/s12041-008-0002-x.
  • Kampstra ASB, Toes REM. (2017). HLA class II and rheumatoid arthritis: The bumpy road of revelation. Immunogenetics, 69, 597–603. doi:10.1007/s00251-017-0987-5.
  • Kim SK, Chung JH, Kim DH, et al. (2012). Lack of association between promoter polymorphisms of HLA-G gene and rheumatoid arthritis in Korean population. Rheumatol Int, 32, 509–512. doi:10.1007/s00296-010-1735-4.
  • Klareskog L, Stolt P, Lundberg K, et al. (2006). A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum, 54, 38–46. doi:10.1002/art.21575.
  • Kooloos WM, Wessels JA, van der Straaten T, et al. (2010). Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics, 11, 163–175. doi:10.2217/pgs.09.139.
  • Lee YH, Bae S-C. (2015). Association between a functional HLA-G 14-bp insertion/deletion polymorphism and susceptibility to autoimmune diseases: A meta-analysis. Cell Mol Biol Noisy–Gd Fr, 61, 24–30.
  • Lee YH, Bae S-C, Song GG. (2015). Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int, 35, 953–961. doi:10.1007/s00296-014-3155-3.
  • Mariaselvam CM, Chaaben AB, Salah S, et al. (2015). Human leukocyte antigen-G polymorphism influences the age of onset and autoantibody status in rheumatoid arthritis. Tissue Antigens, 85(3), 182–189. doi:10.1111/tan.12521.
  • Miller SA, Dykes DD, Polesky HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215. doi:10.1093/nar/16.3.1215.
  • Okada Y, Suzuki A, Ikari K, et al. (2016). Contribution of a non-classical HLA gene, HLA-DOA, to the risk of rheumatoid arthritis. Am J Hum Genet, 99, 366–374. doi:10.1016/j.ajhg.2016.06.019.
  • Okada Y, Wu D, Trynka G, et al. (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 506, 376–381. doi:10.1038/nature12873.
  • Ouni N, Chaaben AB, Kablouti G, et al. (2019). The impact of HLA-G 3ʹUTR polymorphisms in breast cancer in a Tunisian population. Immunol Invest, 48, 521–532. doi:10.1080/08820139.2019.1569043.
  • Padyukov L, Seielstad M, Ong RTH, et al. (2011). A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis, 70, 259–265. doi:10.1136/ard.2009.126821.
  • Raychaudhuri S, Sandor C, Stahl EA, et al. (2012). Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet, 44, 291–296. doi:10.1038/ng.1076.
  • Rebmann V, König L, Nardi FDS, et al. (2016). The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology. Front Immunol, 7, 173. doi:10.3389/fimmu.2016.00173.
  • Rizzo R, Bortolotti D, Bolzani S, Fainardi E. (2014). HLA-G molecules in autoimmune diseases and infections. Front Immunol, 5, 592. doi:10.3389/fimmu.2014.00592.
  • Rizzo R, Rubini M, Govoni M, et al. (2006). HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics, 16, 615–623. doi:10.1097/01.fpc.0000230115.41828.3a.
  • Rizzo R, Trentini A, Bortolotti D, et al. (2013). Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cell Biochem, 381, 243–255. doi:10.1007/s11010-013-1708-5.
  • Rokhafrooz S, Ghadiri A, Ghandil P, et al. (2018). Association between HLA-G 14bp gene polymorphism and serum sHLA-G protein concentrations in preeclamptic patients and normal pregnant women. Immunol Invest, 47, 558–568. doi:10.1080/08820139.2018.1467925.
  • Rosenblum MD, Remedios KA, Abbas AK. (2015). Mechanisms of human autoimmunity. J Clin Invest, 125, 2228–2233. doi:10.1172/JCI78088.
  • Rousseau P, Le Discorde M, Mouillot G, et al. (2003). The 14 bp deletion-insertion polymorphism in the 3ʹ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol, 64, 1005–1010. doi:10.1016/j.humimm.2003.08.347.
  • Rudan I, Sidhu S, Papana A, Global Health Epidemiology Reference Group (GHERG). (2015). Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J Glob Health, 5, 010409. doi:10.7189/jogh.05.010409.
  • Sabbagh A, Luisi P, Castelli EC, Gineau L, Courtin D, Milet J, Massaro JD, Laayouni H, Moreau P, Donadi EA, et al. 2014. Worldwide genetic variation at the 3ʹ untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun. 15(2):95–106. doi:10.1038/gene.2013.67.
  • Shiroishi M, Kuroki K, Rasubala L, et al. (2006). Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA, 103, 16412–16417. doi:10.1073/pnas.0605228103.
  • Sokka T, Kautiainen H, Pincus T, et al. (2010). Work disability remains a major problem in rheumatoid arthritis in the 2000s: Data from 32 countries in the QUEST-RA study. Arthritis Res Ther, 12, R42. doi:10.1186/ar2951.
  • Stamp LK, O’Donnell JL, Chapman PT, et al. (2009). Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis, 68, 154–155. doi:10.1136/ard.2008.089383.
  • Sundaresh A, Wu C-L, Chinnadurai RK, et al. (2018). The HLA-G genetic contribution to bipolar disorder: A trans-ethnic replication. Immunol Invest, 47, 593–604. doi:10.1080/08820139.2018.1469649.
  • Tan Z, Randall G, Fan J, et al. (2007). Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet, 81, 829–834. doi:10.1086/521200.
  • Tawfeek GA-E, Alhassanin S. (2018). HLA-G gene polymorphism in Egyptian patients with non-Hodgkin lymphoma and its clinical outcome. Immunol Invest, 47, 315–325. doi:10.1080/08820139.2018.1430826.
  • Veit TD, Chies JAB. (2009). Tolerance versus immune response – microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol, 20, 229–231. doi:10.1016/j.trim.2008.11.001.
  • Veit TD, de Lima CPS, Cavalheiro LC, et al. (2014). HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens, 83, 260–266. doi:10.1111/tan.12311.
  • Veit TD, Vianna P, Scheibel I, et al. (2008). Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens, 71, 440–446. doi:10.1111/j.1399-0039.2008.01019.x.
  • Zanelli E, Breedveld FC, de Vries RR. (2000). HLA class II association with rheumatoid arthritis: Facts and interpretations. Hum Immunol, 61, 1254–1261. doi:10.1016/S0198-8859(00)00185-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.